OIS@ASRS 2016 Videos
Anthony P. Adamis, MD Senior Vice President and Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science at Genentech, recounts the influence famous…Read More
Andrew Gitkin, managing director and head of West Coast biotechnology investment banking at Piper Jaffray, says ophthalmology remains one of the “top two or three”…Read More
Jonathan Norris, a managing director for SVB’s Healthcare practice, says fund-raising numbers for biotech start-ups is strong while Medtech is seeing a decline. While VCs…Read More
Tarek S. Hassan, M.D., Professor of Ophthalmology at Oakland University William Beaumont School of Medicine and Fellowship Director at Associated Retinal Consultants in Royal Oak,…Read More
Jay S. Duker, MD, is the Director of the New England Eye Center (NEEC), Professor and Chairman of Ophthalmology at Tufts Medical Center and Tufts…Read More
New ASRS President Mark S. Humayun, MD, PhD, shares the challenges of entrepreneurship in innovation. Co-Inventor of the world’s first FDA approved artificial retinal prosthesis…Read More
Tracy Saxton, investment director at Roche Venture Fund, began her career at the research bench but quickly founder he way into the corporate side working…Read More
Adnan Butt, senior biotechnology analyst at RBC Capital Markets, says interest in ophthalmology is on the rise for products targeting both the posterior and anterior…Read More
Frederic Guerard, worldwide business franchise head, ophthalmology for Novartis, sits down with OIS TV to explain how the “conscious uncoupling” with Alcon will impact Novartis’…Read More
Many see optical coherence tomography (OCT) angiography as a promising new technology, but David Huang, MD, PhD, Peterson professor of ophthalmology at the Casey Eye…Read More
OIS founder and co-chair Emmett Cunningham Jr., MD, welcomes attendees to the first annual Ophthalmology Innovation Summit held prior to the annual meeting of the…Read More
Aron Shapiro, vice president at Ora Inc., gives a comprehensive overview of the challenges and opportunities of retina therapies. Shapiro discusses Ora’s early work with…Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.